Results 1 - 20 of 714,767 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Digital Resources/Online E-Resources (58,072)
- Peer-reviewed Journals (41,505)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escapeNature reviews. Immunology, 2021-10, Vol.21 (10), p.626-636 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00592-1 ;PMID: 34373623Full text available |
| 2 |
Material Type: Article
|
|
Myocarditis With COVID-19 mRNA VaccinesCirculation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357Full text available |
| 3 |
Material Type: Article
|
|
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246Digital Resources/Online E-Resources |
| 4 |
Material Type: Article
|
|
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2187-2201 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101544 ;PMID: 33882225Digital Resources/Online E-Resources |
| 5 |
Material Type: Article
|
|
The lightning-fast quest for COVID vaccines - and what it means for other diseasesNature (London), 2021-01, Vol.589 (7840), p.16-18 [Peer Reviewed Journal]ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-03626-1 ;PMID: 33340018Full text available |
| 6 |
Material Type: Article
|
|
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432Digital Resources/Online E-Resources |
| 7 |
Material Type: Article
|
|
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 VaccineNew England Journal of Medicine, 2021-05, Vol.384 (19), p.1824-1835 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034201 ;PMID: 33440088Digital Resources/Online E-Resources |
| 8 |
Material Type: Article
|
|
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccineNew England Journal of Medicine, 2021-09, Vol.385 (13), p.1172-1183 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107659 ;PMID: 34192426Digital Resources/Online E-Resources |
| 9 |
Material Type: Article
|
|
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deploymentThe Lancet (British edition), 2021-03, Vol.397 (10278), p.1023-1034 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00306-8 ;PMID: 33587887Full text available |
| 10 |
Material Type: Article
|
|
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialThe Lancet (British edition), 2021-09, Vol.398 (10303), p.856-869 [Peer Reviewed Journal]2021 ;Crown Copyright © 2021 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Sep 4, 2021 ;Crown Copyright © 2021 Published by Elsevier Ltd. 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01694-9 ;PMID: 34370971Full text available |
| 11 |
Material Type: Article
|
|
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccinesJournal of allergy and clinical immunology, 2021-06, Vol.147 (6), p.2075 [Peer Reviewed Journal]Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1097-6825 ;DOI: 10.1016/j.jaci.2021.04.002 ;PMID: 33857566Digital Resources/Online E-Resources |
| 12 |
Material Type: Article
|
|
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impactNature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702Full text available |
| 13 |
Material Type: Article
|
|
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689Full text available |
| 14 |
Material Type: Article
|
|
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataThe Lancet (British edition), 2021-05, Vol.397 (10289), p.2043-2046 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01115-6 ;PMID: 33991480Full text available |
| 15 |
Material Type: Article
|
|
COVID-19 vaccination: The road aheadScience (American Association for the Advancement of Science), 2022-03, Vol.375 (6585), p.1127-1132 [Peer Reviewed Journal]Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abn1755 ;PMID: 35271316Digital Resources/Online E-Resources |
| 16 |
Material Type: Article
|
|
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020-12, Vol.396 (10267), p.1979-1993 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32466-1 ;PMID: 33220855Digital Resources/Online E-Resources |
| 17 |
Material Type: Article
|
|
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further ConsiderationsFrontiers in immunology, 2021-04, Vol.12, p.669339-669339 [Peer Reviewed Journal]Copyright © 2021 He, Mao, Zhang, Bian, Gao, Wang, Xu and Liang. ;Copyright © 2021 He, Mao, Zhang, Bian, Gao, Wang, Xu and Liang 2021 He, Mao, Zhang, Bian, Gao, Wang, Xu and Liang ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.669339 ;PMID: 33912196Full text available |
| 18 |
Material Type: Article
|
|
Multisociety Statement on COVID-19 Vaccination as a Condition of Employment for Healthcare PersonnelInfection Control & Hospital Epidemiology, 2021-07, p.1 [Peer Reviewed Journal]2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;DOI: 10.1017/ice.2021.322Digital Resources/Online E-Resources |
| 19 |
Material Type: Article
|
|
COVID-19 vaccinations: The unknowns, challenges, and hopesJournal of medical virology, 2022-04, Vol.94 (4), p.1336 [Peer Reviewed Journal]2021 Wiley Periodicals LLC. ;EISSN: 1096-9071 ;DOI: 10.1002/jmv.27487 ;PMID: 34845731Digital Resources/Online E-Resources |
| 20 |
Material Type: Article
|
|
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialThe Lancet infectious diseases, 2021-12, Vol.21 (12), p.1654-1664 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00396-0 ;PMID: 34324836Full text available |
Results 1 - 20 of 714,767 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Digital Resources/Online E-Resources (58,072)
- Peer-reviewed Journals (41,505)
Refine My Results
Creation Date
- Before 2010 (6)
- 2010 To 2013 (4)
- 2014 To 2016 (13)
- 2017 To 2020 (81,481)
- After 2020 (633,352)
-
More options
New Records
- New From Last Week (223)
- New From Last Month (2,363)
- New From Last 3 Month (6,751)
-
More options
Resource Type
- Newsletter Articles (490,682)
- Newspaper Articles (118,502)
- Articles (60,669)
- Web Resources (22,622)
- magazinearticle (12,600)
- Text Resources (7,209)
- Reports (2,080)
- Reviews (122)
- Book Chapters (58)
- Videos (57)
- Conference Proceedings (44)
- Books (43)
- Thesises (postgraduate) (26)
- Datasets (25)
- Audio (17)
- References (8)
- Standards (3)
-
More options
Subject
- Covid-19 Vaccines (709,200)
- Coronaviruses (612,593)
- Immunization (304,028)
- Covid-19 (219,849)
- Pandemics (215,243)
- Vaccines (181,521)
- Disease Transmission (85,307)
- Severe Acute Respiratory Syndrome Coronavirus 2 (71,250)
- Public Health (58,708)
- Infections (47,968)
- Science & Technology (34,747)
- Medical Research (32,648)
- Life Sciences & Biomedicine (31,778)
- Clinical Trials (26,968)
- Presidents (24,079)
- Humans (23,111)
- Pharmaceutical Industry (22,378)
- Fda Approval (21,915)
- Infectious Diseases (21,523)
- Earnings Per Share (21,499)
-
More options
Databases
- ProQuest Central (701,450)
- MEDLINE (22,910)
- DOAJ Directory of Open Access Journals (22,274)
- PubMed Central (21,691)
- Coronavirus Research Database (18,757)
- ROAD: Directory of Open Access Scholarly Resources (18,657)
- GFMER Free Medical Journals (14,305)
- HighWire Press (Free Journals) (3,885)
- ProQuest One Psychology (3,496)
- Springer Nature OA/Free Journals (2,610)
- Wiley-Blackwell Open Access Titles (1,723)
- Freely Accessible Journals (1,386)
- Nature Open Access (1,282)
- Taylor & Francis Open Access (1,238)
- Public Library of Science (PLoS) (1,092)
- Journals@Ovid Open Access Journal Collection Rolling (973)
- BMJ Open Access Journals (946)
- U.S. Government Documents (911)
- Centers for Disease Control and Prevention (517)
- JSTOR Early Journal Content (444)
-
More options
Language
- English (703,416)
- French (5,765)
- Spanish (5,105)
- Japanese (2,202)
- Portuguese (734)
- German (502)
- Russian (280)
- Arabic (247)
- Urdu (227)
- Turkish (199)
- Azerbaijani (94)
- Chinese (91)
- Norwegian (50)
- Italian (38)
- Kinyarwanda (36)
- Korean (24)
- Polish (18)
- Hungarian (13)
- Dutch (12)
- Afrikaans (10)
-
More options
Journal Title
- Asia News Monitor (19,660)
- Business Insider (3,103)
- Chicago Tribune (4,784)
- Congressional Documents And Publications (3,060)
- Mint (4,515)
- New York Times (4,163)
- The Economic Times (3,573)
- The Financial Times (5,558)
- The Wall Street Journal. Eastern Edition (7,139)
- The Washington Post (4,006)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||